The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-5.4% to $1,145.00
Predicted High$1,188.00in 2 weeks
Predicted Low$1,140.00at 4 months
Max Drawdown (predicted)-5.8%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Jul 30, 2026 1:08 am
Bear
LLY trends lower to
$1,145.00
(-5.4% from $1,210.02)
by Jan 2027.
decay
ThesisLLY trades far above the only available anchor (bear scenario ~$435) with negative value lens and softening GLP-1 narrative, but quality is elite and beta is very low, cushioning near-term downside. Expect modest drift lower over 6 months as competitive pressure compresses the premium, with a stress-regime wobble first and stabilization as the name finds defensive bid.
Invalidated ifA decisive GLP-1 competitive win (Phase 3 obesity readout, tirzepatide label expansion) or LLY breaking above $1,300 on volume invalidates the fade; conversely a break under $1,050 accelerates it.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $1,210.02 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Jul 30, 2026
—
$1,210.02at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 13, 2026
$1,123.74–$1,296.30typical range · internal point $1,188.00
What actually happened:
closed $1,220.28
on Aug 12, 2026 = +0.9% vs the call
(predicted -1.8%)
· direction HIT
(called flat, was flat)
· off by 2.7 pp
· accuracy 9/10
· typical range ±7.1%:
inside the band
· S&P +4.2%
over the same window — beat it
1 month
Aug 30, 2026
$1,084.98–$1,335.06typical range · internal point $1,175.00
Q3 print window; quality supports but value gap weighs
4 months
Nov 30, 2026
$1,140.00
—
-5.8%
4/10
Gradual mean reversion toward fair-value gravity
5 months
Dec 30, 2026
$1,155.00
—
-4.5%
3/10
Year-end defensive rotation offers modest bid
6 months
Jan 30, 2027
$1,145.00
—
-5.4%
3/10
Path uncertain; value overhang persists into 2027
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.